BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18413388)

  • 21. Not gene therapy, but genetic surgery-the right strategy to attack cancer.
    Sverdlov ED
    Mol Gen Microbiol Virol; 2009; 24(3):93-113. PubMed ID: 32214647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging grafted cells with [18F]FHBG using an optimized HSV1-TK mammalian expression vector in a brain injury rodent model.
    Salabert AS; Vaysse L; Beaurain M; Alonso M; Arribarat G; Lotterie JA; Loubinoux I; Tafani M; Payoux P
    PLoS One; 2017; 12(9):e0184630. PubMed ID: 28926581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Analysis of Human Nucleoside Kinase-Based Reporter Systems for PET Imaging.
    Lee JT; Zhang H; Moroz MA; Likar Y; Shenker L; Sumzin N; Lobo J; Zurita J; Collins J; van Dam RM; Ponomarev V
    Mol Imaging Biol; 2017 Feb; 19(1):100-108. PubMed ID: 27393689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An in vitro and in vivo evaluation of a reporter gene/probe system hERL/(18)F-FES.
    Qin C; Lan X; He J; Xia X; Tian Y; Pei Z; Yuan H; Zhang Y
    PLoS One; 2013; 8(4):e61911. PubMed ID: 23593502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography (PET) imaging with (18)F-based radiotracers.
    Alauddin MM
    Am J Nucl Med Mol Imaging; 2012; 2(1):55-76. PubMed ID: 23133802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications.
    Yaghoubi SS; Campbell DO; Radu CG; Czernin J
    Theranostics; 2012; 2(4):374-91. PubMed ID: 22509201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzymes to die for: exploiting nucleotide metabolizing enzymes for cancer gene therapy.
    Ardiani A; Johnson AJ; Ruan H; Sanchez-Bonilla M; Serve K; Black ME
    Curr Gene Ther; 2012 Apr; 12(2):77-91. PubMed ID: 22384805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging virus-associated cancer.
    Fu DX; Foss CA; Nimmagadda S; Ambinder RF; Pomper MG
    Curr Pharm Des; 2008; 14(28):3048-65. PubMed ID: 18991718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs.
    Likar Y; Dobrenkov K; Olszewska M; Vider E; Shenker L; Cai S; Pillarsetty N; Hricak H; Ponomarev V
    J Nucl Med; 2008 May; 49(5):713-20. PubMed ID: 18413388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PET imaging of HSV1-tk mutants with acquired specificity toward pyrimidine- and acycloguanosine-based radiotracers.
    Likar Y; Dobrenkov K; Olszewska M; Shenker L; Cai S; Hricak H; Ponomarev V
    Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1273-82. PubMed ID: 19259663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs.
    Najjar AM; Nishii R; Maxwell DS; Volgin A; Mukhopadhyay U; Bornmann WG; Tong W; Alauddin M; Gelovani JG
    J Nucl Med; 2009 Mar; 50(3):409-16. PubMed ID: 19223410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET of cardiac transgene expression: comparison of 2 approaches based on herpesviral thymidine kinase reporter gene.
    Miyagawa M; Anton M; Haubner R; Simoes MV; Städele C; Erhardt W; Reder S; Lehner T; Wagner B; Noll S; Noll B; Grote M; Gambhir SS; Gansbacher B; Schwaiger M; Bengel FM
    J Nucl Med; 2004 Nov; 45(11):1917-23. PubMed ID: 15534063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs.
    Likar Y; Zurita J; Dobrenkov K; Shenker L; Cai S; Neschadim A; Medin JA; Sadelain M; Hricak H; Ponomarev V
    J Nucl Med; 2010 Sep; 51(9):1395-403. PubMed ID: 20810757
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.